-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Bsz9LEjY5CsdhxNfXd+QUV5YfY2qO9r7eIFn8DPmXXPEACbffQPYWCyMvcgDaUs0 pvXvxrV1/jQhHbxHrW7euQ== 0000950124-01-000813.txt : 20010223 0000950124-01-000813.hdr.sgml : 20010223 ACCESSION NUMBER: 0000950124-01-000813 CONFORMED SUBMISSION TYPE: 5 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20001231 FILED AS OF DATE: 20010214 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: PHARMACIA CORP /DE/ CENTRAL INDEX KEY: 0000067686 STANDARD INDUSTRIAL CLASSIFICATION: CHEMICALS & ALLIED PRODUCTS [2800] IRS NUMBER: 430420020 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 5 SEC ACT: SEC FILE NUMBER: 001-02516 FILM NUMBER: 1541829 BUSINESS ADDRESS: STREET 1: 100 ROUTE 206 NORTH CITY: PEAPACK STATE: NJ ZIP: 07977 BUSINESS PHONE: 9089018000 MAIL ADDRESS: STREET 1: 100 ROUTE 206 NORTH CITY: PEAPACK STATE: NJ ZIP: 07977 FORMER COMPANY: FORMER CONFORMED NAME: MONSANTO CO DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: MONSANTO CHEMICAL CO DATE OF NAME CHANGE: 19711003 COMPANY DATA: COMPANY CONFORMED NAME: ANDO GORAN CENTRAL INDEX KEY: 0001110748 STANDARD INDUSTRIAL CLASSIFICATION: [] OFFICER STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 5 BUSINESS ADDRESS: STREET 1: 100 ROUTE 206 NORTH CITY: PEAPACK STATE: NJ ZIP: 07977 BUSINESS PHONE: 3146944492 5 1 c60073ae5.txt FORM 5 1 - ------ FORM 5 - ------ / / Check box if no U.S. SECURITIES AND EXCHANGE COMMISSION longer subject to WASHINGTON, DC 20549 Section 16. Form 4 or Form 5 ANNUAL STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP obligations may continue. See Filed pursuant to Section 16(a) of the Securities Instruction 1(b) Exchange Act of 1934, / / Form 3 Holdings Section 17(a) of the Public Utility Reported Holding Company Act of 1935 or Section 30(f) of / / Form 4 the Investment Company Act Transactions of 1940 Reported - ------------------------------------------------------------------------------------------------------------------------------------ 1. Name and Address of Reporting Person(1) 2. Issuer Name and Ticker or Trading Symbol 7. Individual or Joint/Group Filing (Check applicable line) X Form filed by One Reporting ---- Person Form Filed by More Than One Goran, Ando PHARMACIA CORPORATION (PHA) ---- Reporting Person - --------------------------------------------------------------------------------------------- (Last) (First) (Middle) 3. IRS Identification 4. Statement for Number of Reporting Month/Year Person, if an Entity (Voluntary) 100 Route 206 North December 31, 2000 - ------------------------------------------- ------------------- (Street) 5. If Amendment, Peapack, New Jersey 07977 Date of Original - ------------------------------------------- (Month/Year) (City) (State) (Zip) 6. Relationship of Reporting Person to Issuer (Check all applicable) Director 10% Owner ---- --- X Officer (give Other (Specify ---- title --- below) below) Executive Vice President, and President Research and Development ------------------------- - ------------------------------------------------------------------------------------------------------------------------------------ TABLE I -- NON-DERIVATIVE SECURITIES ACQUIRED, DISPOSED OF, OR BENEFICIALLY OWNED - ------------------------------------------------------------------------------------------------------------------------------------ 1. Title of Security 2. Trans- 3. Transac- 4. Securities Acquired (A) 5. Amount of Se- 6. Owner- 7. Nature (Instr. 3) action tion or Disposed of (D) curities Benefi- ship of In- Date Code (Instr. 3, 4 and 5) cially Owned Form: direct (Instr. 8) at End Month Direct Benefi- (Month/ (Instr. 3 and 4) (D) or cial Day/ ---------------------------- Indirect Owner- Year) Amount (A) or (D) Price (I) ship (Instr. 4) (Instr. 4) - ------------------------------------------------------------------------------------------------------------------------------------ Common Stock 24,161(1) D - ------------------------------------------------------------------------------------------------------------------------------------ Common Stock 3,108 I By Savings Plans - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ 1 If the form is filed by more than one Reporting Person, see Instruction 4(b)(v). Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly
2
FORM 5 (CONTINUED) TABLE II -- DERIVATIVE SECURITIES ACQUIRED, DISPOSED OF, OR BENEFICIALLY OWNED (E.G., PUTS, CALLS, WARRANTS, OPTIONS, CONVERTIBLE SECURITIES) - ------------------------------------------------------------------------------------------------------------------------------------ 1. Title of Derivative 2. Conver- 3. Trans- 4. Trans- 5. Number of 6. Date Exer- 7. Title and Amount 8. Price Security sion or action action Derivative cisable and of Underlying of (Instr. 3) Exercise Date Code Securities Ac- Expiration Securities Deriv- Price of (Month/ (Instr. 8) quired (A) or Date (Instr. 3 and 4) ative Deriv- Day/ Disposed of (D) (Month/Day/ Secur- ative Year) (Instr. 3, 4, Year) ity Security and 5) (Instr. 5) ----------------------------------- Date Expira- Amount or --------------- Exer- tion Title Number of (A) (D) cisable Date Shares - ------------------------------------------------------------------------------------------------------------------------------------ Option (right to buy) $33.64 (2) 2/24/08 Common 47,500 Stock - ------------------------------------------------------------------------------------------------------------------------------------ Option (right to buy) $45.90 (2) 2/16/09 Common 119,000 Stock - ------------------------------------------------------------------------------------------------------------------------------------ Option (right to buy) $41.23 (2) 2/14/10 Common 119,000 Stock - ------------------------------------------------------------------------------------------------------------------------------------ Option (right to buy) $51.59 (3) 6/1/10 Common 125,000 Stock - ------------------------------------------------------------------------------------------------------------------------------------ Performance 1-for-1 6/1/00 A 100,000 (4) (4) Common 100,000 $51.59 Share Units Stock - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ 9. Number of 10. Ownership 11. Nature of Derivative of Derivative Indirect Securities Security: Beneficial Beneficially Direct (D) Ownership Owned at End or Indirect (I) (Instr. 4) of Month (Instr. 4) (Instr. 4) - ------------------------------------------------------------------------------------------------------- 47,500 D - ------------------------------------------------------------------------------------------------------- 166,500 D - ------------------------------------------------------------------------------------------------------- 285,500 D - ------------------------------------------------------------------------------------------------------- 410,500 D - ------------------------------------------------------------------------------------------------------- 510,500 D - ------------------------------------------------------------------------------------------------------- - ------------------------------------------------------------------------------------------------------- Explanation of Responses: (1) Includes 6,702 shares held pursuant to a Deferred Compensation Plan and 204 deferred dividend equivalents on Deferred Incentive Compensation. (2) Options are currently exercisable. (3) Options become exercisable for one-third of the shares on each of 6/1/01, 6/1/02 and 6/1/03. (4) Performance share units will be earned on the earlier of 12/31/04 (unless employment terminates) or the date of a change-in-control with the ultimate payout in the range of 0% to 125% of the number of units granted (100,000) based upon the Company's relative total shareholder return compared to peer companies and absolute total shareholder return over the performance period. /s/ Don Schmitz* 02/14/01 ------------------------------- -------- Signature of Reporting Person(1) Date *Don Schmitz, attorney-in-fact for Goran Ando. (1) Intentional misstatements or omission of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Note. File three copies of this form, one of which must be manually signed. Page 2 If space provided is insufficient, see Instruction 6 for procedure.
-----END PRIVACY-ENHANCED MESSAGE-----